Behind Plastopil's Expansion: Heavy Working Capital and Short-Term Funding That Still Needs Proof
Plastopil ended 2025 with NIS 161 million of operating working capital against only NIS 25.5 million of reported net working capital. This is not an immediate liquidity crunch, but it does mean the expansion is still leaning on short-term, floating-rate bank funding rather than on internally generated cash.
What This Follow-up Is Isolating
The main article already dealt with whether Plastopil can broaden its industrial platform without giving up control over margin quality. This follow-up isolates the layer that makes that question matter: how much working capital the business needs, how much short-term credit is funding it, and whether that structure is already proving itself as a cash platform rather than just a growth platform.
The picture is clear. In the March 2026 investor presentation, Plastopil shows operating working capital of NIS 161 million for 2025, up from NIS 147 million in 2024. At the same time, reported net working capital, current assets minus current liabilities, stood at just NIS 25.5 million at year-end. That gap is the core of the story: the activity itself is tying up more and more cash in receivables and inventory, while actual liquidity headroom is being compressed because the balancing item is mainly short-term bank credit.
This is still not an emergency picture. The company reports NIS 24.4 million of unused short-term credit lines, and it says it met all of its financial covenants at the end of 2025. But it is also not a self-funded platform. When short-term bank credit rises to NIS 122.5 million, net debt reaches NIS 157.1 million, and cash flow from operations falls to only NIS 11.6 million, the question is no longer whether Plastopil has become a broader platform. The question is whether that expansion is already able to carry itself.
Heavy Working Capital Is Not a One-off Problem, It Is Part of the Operating Model
What matters here is that this burden does not look accidental. Plastopil describes a raw-material inventory policy of roughly 6 to 8 weeks of production on average, while also explaining that it hardly carries finished-goods inventory and instead holds raw materials and work in process in order to maintain delivery times. That is an important distinction. The inventory load is not mainly a symptom of weak demand. It is an operating requirement of the service model.
Customer terms tell the same story. In the domestic market, payment terms are generally current + 30 to current + 120 days. In export, terms are 60 to 90 days from the bill of lading date. Supplier credit, by contrast, runs on average from current + 60 to current + 120. In the company’s 2025 quarterly average table, Plastopil shows 81 credit days for overseas customers, 83 days for domestic customers, and only 78 days versus suppliers. In other words, the company is not benefiting from excess supplier financing that cancels out customer credit. It is carrying part of that gap on its own balance sheet.
| Item | 2024 | 2025 | What changed |
|---|---|---|---|
| Receivables | 91.4 | 93.1 | A modest increase, but a large credit base remains locked on the balance sheet |
| Inventory | 116.7 | 125.3 | This is the working-capital line that rose the fastest |
| Suppliers | 61.5 | 57.1 | Supplier financing actually fell |
| Operating working capital | 147.0 | 161.0 | Up by roughly NIS 14 million |
| Reported net working capital | 42.7 | 25.5 | Liquidity headroom fell sharply |
The sharpest point is that operating working capital of NIS 161 million is already larger than the NIS 149 million of equity shown in the presentation. That does not mean the balance sheet is broken. It does mean the industrial platform relies heavily on external funding in order to hold inventory, serve customers, and keep the machine turning. When volume growth demands more working capital, the bank becomes part of the model rather than a support layer around it.
Cash Flow: The Right Frame Here Is All-in Cash Flexibility
The correct frame for this continuation is all-in cash flexibility, not normalized cash generation. The reason is simple. The issue here is not what the business might generate in a cleaner, adjusted scenario. The issue is how much cash is actually left after the real cash uses Plastopil paid in 2025.
The cash flow statement shows why funding remains a thesis-critical layer. Cash flow from operations fell to NIS 11.6 million from NIS 17.3 million a year earlier. Within working-capital items, receivables absorbed NIS 9.4 million, inventory absorbed another NIS 1.6 million, and the decline in supplier balances absorbed a further NIS 4.3 million. Those three lines alone took more than NIS 15 million out of cash. At the same time, interest paid came to NIS 14.1 million. This is not the cash profile of a platform that has already moved beyond balance-sheet support.
From there, the picture gets even cleaner. In 2025, NIS 11.6 million of cash flow from operations did not even cover the reported NIS 21.8 million of CAPEX. Once you add NIS 6.2 million spent on companies first consolidated, NIS 2.0 million of intangible-asset purchases, NIS 9.5 million of lease-principal repayments, and NIS 15.7 million of long-term loan repayments, you get a very direct picture of real cash uses that the business did not fund on its own.
That is the real distinction between a broader platform and a funded platform. Plastopil ended 2025 with cash up by NIS 2.9 million, but that increase was not built out of excess internal cash. It was built because net short-term borrowing rose by NIS 28.5 million and the company took another NIS 18.0 million of long-term loans. In other words, year-end cash looks steadier than the underlying cash economics.
Floating Rates, Credit Lines, and Covenant Design
The funding layer itself adds another yellow flag. The short-term credit note shows NIS 107.9 million of short-term bank loans at prime-linked rates, plus NIS 14.5 million of current maturities from long-term borrowing. The long-term debt note adds NIS 43.1 million of bank debt at variable rates, against only NIS 0.1 million of fixed-rate unlinked debt and NIS 0.5 million of dollar-linked debt. The company also states explicitly that it does not hedge interest-rate exposure. In plain terms, most of the bank debt stack moves with rates.
| Funding layer | End 2025 | What it means |
|---|---|---|
| Short-term bank credit | NIS 122.5 million | Roughly 74% of total bank debt already sits in the short-term bucket |
| Long-term bank debt | NIS 43.2 million | The vast majority is variable-rate |
| Average interest rate on non-earmarked loans | 6.59% | Financing cost is already material to the income statement |
| Unused short-term lines | NIS 24.4 million | This provides air, but not a wide cushion against the debt structure |
Covenants are also telling you what the banks are really watching. The company must keep tangible equity at no less than 25% of tangible balance sheet assets, and at the end of 2025 it reports 27.1%, so the room exists but is not wide. In March 2026, bank C also agreed to replace the old financing-liabilities-to-EBITDA test with a new net-debt-minus-working-capital-to-EBITDA ceiling of 4. There is also a cap on net short-term debt relative to working capital. That matters. The banks are not looking only at scale or EBITDA. They are increasingly looking at the same issue this continuation isolates: how much debt is left after the working-capital layer is taken into account, and how much of that funding remains short-dated.
So the right read on 2025 is not “the company is in a squeeze,” but neither is it “the balance sheet has already proved itself.” The right read is that the banks are still escorting the expansion phase, and they are testing it through a more cash-sensitive and balance-sheet-sensitive lens.
What Still Has to Be Proved
First proof point: operating working capital has to stop growing faster than the company’s ability to turn profit into cash. If receivables and inventory keep expanding without help from suppliers or stronger cash conversion, every operating improvement will remain bank-dependent.
Second proof point: cash flow from operations has to move back toward covering at least regular CAPEX and lease cash, without another step-up in short-term credit. That is not a theoretical test. It is the threshold for deciding whether the platform is starting to fund itself.
Third proof point: short-term debt has to stabilize. As long as roughly three quarters of bank debt sits in the short bucket, even a decent year can still be eroded if rates do not fall or if working capital opens up again.
Fourth proof point: covenant room has to widen organically, not merely remain within the current frame. Meeting the tests at the end of 2025 matters, but it is not the end of the story. It only means the company finished the year inside the box.
Conclusions
Plastopil is not being tripped up here by one weak cash line or one weak quarter. The deeper point is that the broader activity base is tying up more inventory and customer credit while real liquidity flexibility is leaning more heavily on short-term, floating-rate bank funding. That is why operating working capital rose to NIS 161 million, net debt climbed to NIS 157.1 million, and cash flow from operations fell to NIS 11.6 million, without an immediate crisis showing up on the surface.
The thesis here is fairly sharp: Plastopil has already built a broader platform, but its funding layer still needs proof. If 2026 brings a slowdown in working-capital build, stabilization in short-term credit, and better cash coverage of CAPEX and lease cash, the balance sheet will start to look like a growth platform. If not, the market is likely to keep reading the expansion as growth that is being bought with working capital and short debt rather than growth that has already learned to fund itself.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.